Trends in Heart Failure Outcomes From a Large, Geographically Diverse Cohort During the COVID-19 PandemicThe evolving coronavirus disease 2019 (COVID-19) pandemic has presented extraordinary challenges to the health of populations globally. As our understanding of the virus continues to grow at a rapid pace, it has become increasingly clear that the clinical manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection range widely and are in large part dictated by age, underlying comorbidities, and vaccination status. Robust epidemiologic data during the past years have underscored that individuals with chronic health conditions including cardiovascular disease, diabetes mellitus, immunosuppression, tobacco use, and obesity carry a significantly greater risk of falling critically ill with SARS-CoV-2.
Explaining Unexplained Hypoglycemia Due To Insulin AnalogsHypoglycemia is a potentially life-threatening condition that requires urgent medical attention. Most hypoglycemia in patients with diabetes is related to medication use, and recent studies have indicated the contributions of insulin analogs in cases of hypoglycemia.1,2 Even in patients without diabetes, it is important to exclude insulin administration as a cause of hypoglycemia, yet detection of insulin analogs is not straightforward. The small structural changes that result in favorable pharmacokinetics of insulin analogs also affect the detection of analog insulin by immunoassays, culminating in varying results from different commercially available assays.
The Imposter Syndrome in PhysiciansImposter syndrome (IS), also known as imposter phenomenon or imposterism, is defined as feelings of uncertainty, inadequacy, and being undeserving of one’s achievements despite evidence to the contrary. Imposter syndrome has 5 subtypes1:
Racial Disparities and Excess Cardiovascular Mortality Before and During the COVID-19 Pandemic: Time for a SolutionHealth disparities are a complex and multifactorial construct involving lack of access to health care, differential treatment modalities, and different outcomes for the same disease based on racial or socioeconomic class. Disparity in health care has garnered an increasing amount of attention from health care providers and health policy experts.1 Several studies have elucidated the effect of health care disparity between different socioeconomic and ethnic groups on cardiovascular (CV) outcomes as well as relating to the ongoing SARS-CoV-2 infection (COVID-19) pandemic.
Ambulatory Remote Patient Monitoring Beyond COVID-19: Engagement and Sustainment ConsiderationsCare delivery innovations in response to the COVID-19 pandemic, particularly digital health solutions, have been wide ranging and impactful. The spectrum of such innovations includes, for example, technology-based screening tools, electronic health record–based protocols, rapid provider onboarding and education, clinical decision support and diagnostics, large-scale data collection with real-time dashboards for tracking and surveillance to monitor outcomes and hospital capacity, and rapid adoption and expansion of telehealth services and remote monitoring to improve safe access to health care and to optimize resource utilization.